Sana Biotechnology, Inc. recently reported improved financial results for the third quarter and nine months ended September 30, 2025, with net losses narrowing to US$42.15 million for the quarter and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback